• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Bruce R. Zetter, PhD


  • Banyard J, Chung I, Migliozzi M, Phan DT, Wilson AM, Zetter BR, Bielenberg DR.Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.BMC Cancer. 2014;14(1):387.
  • Shi J, Xu Y, Xu X, Zhu X, Pridgen E, Wu J, Votruba AR, Archana S, Zetter BR, Farokhzad OC.Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing.Nanomedicine : Nanotechnology, Biology, And Medicine. 2014 Mar 17.
  • Banyard J, Chung I, Wilson AM, Vetter G, Le Béchec A, Bielenberg DR, Zetter BR.Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model.Sci Rep. 2013;3:3151.
  • Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP.Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.Cancer Res. 2013 Oct 15;73(20):6359-74.
  • Coughlin MF, Bielenberg DR, Lenormand G, Marinkovic M, Waghorne CG, Zetter BR, Fredberg JJ.Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential.Clin Exp Metastasis. 2012 Sep 8.
  • Freeman KW, Bowman BR, Zetter BR.Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling.FASEB J. 2011 Mar;25(3):907-15.
  • Yang W, Cai Q, Lui VW, Everley PA, Kim J, Bhola N, Quesnelle KM, Zetter BR, Steen H, Freeman MR, Grandis JR.Quantitative Proteomics Analysis Reveals Molecular Networks Regulated by Epidermal Growth Factor Receptor Level in Head and Neck Cancer.J Proteome Res. 2010 Jun 4;9(6):3073-82.
  • Spivey KA, Banyard J, Solis LM, Wistuba II, Barletta JA, Gandhi L, Feldman HA, Rodig SJ, Chirieac LR, Zetter BR.Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer.Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1362-72.
  • Mu CJ, Lavan DA, Langer RS, Zetter BR.Self-Assembled Gold Nanoparticle Molecular Probes for Detecting Proteolytic Activity In Vivo.ACS Nano. 2010 Mar 23;4(3):1511-20.
  • Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C, Zetter BR.Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2503-8.
  • Banyard J,Barrows C,Zetter BR.Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1.Genes Chromosomes Cancer. 2009 Jun;48(6):502-9.
  • Feldman AS,Banyard J,Wu CL,McDougal WS,Zetter BR.Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.Clin Cancer Res. 2009 Feb 1;15(3):1024-31.
  • Zetter BR.The scientific contributions of M. Judah Folkman to cancer research.Nat Rev Cancer. 2008 Aug;8(8):647-54.
  • Arap W, Trepel M, Zetter BR, Pasqualini R.Meeting report: innovations in prostate cancer research.Cancer Res. 2008 Feb 1;68(3):635-8.
  • Mangold U, Hayakawa H, Coughlin M, Münger K, Zetter BR.Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification.Oncogene.;27(5):604-13.
  • Mangold U, Hayakawa H, Coughlin M, Mnger K, Zetter BR.Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification.Oncogene. 2008 Jan 24;27(5):604-13.
  • Banyard J, Bao L, Hofer MD, Zurakowski D, Spivey KA, Feldman AS, Hutchinson LM, Kuefer R, Rubin MA, Zetter BR.Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases.Clin Cancer Res. 2007 May 1;13(9):2634-42.
  • Everley PA, Bakalarski CE, Elias JE, Waghorne CG, Beausoleil SA, Gerber SA, Faherty BK, Zetter BR, Gygi SP.Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation.J Proteome Res. 2006 May;5(5):1224-31.
  • Chatterjee SK, Zetter BR.Cancer biomarkers: knowing the present and predicting the future.Future Oncol. 2005 Feb;1(1):37-50. Review.
  • Hutchinson LM, Chang EL, Becker CM, Ushiyama N, Behonick D, Shih MC, DeWolf WC, Gaston SM, Zetter BR.Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer.Clin Biochem. 2005 Jun;38(6):558-71.
  • Hutchinson LM, Chang EL, Becker CM, Shih MC, Brice M, DeWolf WC, Gaston SM, Zetter BR.Use of thymosin beta15 as a urinary biomarker in human prostate cancer.Prostate. 2005 Jul 1;64(2):116-27.
  • Lader AS, Ramoni MF, Zetter BR, Kohane IS, Kwiatkowski DJ.Identification of a Transcriptional Profile Associated with In Vitro Invasion in Non-Small Cell Lung Cancer Cell Lines.Cancer Biol Ther. 2004 Jul;3(7):624-31.
  • Banyard J, Bao L, Zetter BR.Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells.J Biol Chem. 2003 Jun 6;278(23):20989-94.
  • Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA.Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors.Radiology. 2002 Feb;222(2):460-7.
  • Bao L, Loda M, Zetter BR.Thymosin beta15 expression in tumor cell lines with varying metastatic potential.Clin Exp Metastasis. 1998 Apr;16(3):227-33.
  • Zetter BR.Angiogenesis and tumor metastasis.Annu Rev Med. 1998;49:407-24.
  • Anand-Apte B, Zetter BR, Viswanathan A, Qiu RG, Chen J, Ruggieri R, Symons M.Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways.J Biol Chem. 1997 Dec 5;272(49):30688-92.
  • Gold JS, Bao L, Ghoussoub RA, Zetter BR, Rimm DL.Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.Mod Pathol. 1997 Nov;10(11):1106-12.
  • Zetter BR.On target with tumor blood vessel markers.Nat Biotechnol. 1997 Nov;15(12):1243-4.
  • Blatch GL, Lssle M, Zetter BR, Kundra V.Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif.Gene. 1997 Jul 31;194(2):277-82.
  • Lssle M, Blatch GL, Kundra V, Takatori T, Zetter BR.Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases.J Biol Chem. 1997 Jan 17;272(3):1876-84.
  • Yoshida A, Anand-Apte B, Zetter BR.Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor.Growth Factors. 1996;13(1-2):57-64.
  • Kantor JD, Zetter BR.Cell motility in breast cancer.Cancer Treat Res. 1996;83:303-23.
  • Smith RC, Litwin MS, Lu Y, Zetter BR.Identification of an endogenous inhibitor of prostatic carcinoma cell growth.Nat Med. 1995 Oct;1(10):1040-5.
  • Kundra V, Anand-Apte B, Feig LA, Zetter BR.The chemotactic response to PDGF-BB: evidence of a role for Ras.J Cell Biol. 1995 Aug;130(3):725-31.
  • Brightman SE, Blatch GL, Zetter BR.Isolation of a mouse cDNA encoding MTJ1, a new murine member of the DnaJ family of proteins.Gene. 1995 Feb 14;153(2):249-54.
  • Meininger CJ, Brightman SE, Kelly KA, Zetter BR.Increased stem cell factor release by hemangioma-derived endothelial cells.Lab Invest. 1995 Feb;72(2):166-73.
  • Kundra V, Soker S, Zetter BR.Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB.Oncogene. 1994 May;9(5):1429-35.
  • Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Williams LT, Zetter BR.Regulation of chemotaxis by the platelet-derived growth factor receptor-beta.Nature. 1994 Feb 3;367(6462):474-6.
  • Yenush L, Kundra V, White MF, Zetter BR.Functional domains of the insulin receptor responsible for chemotactic signaling.J Biol Chem. 1994 Jan 7;269(1):100-4.
  • Zetter BR.Adhesion molecules in tumor metastasis.Semin Cancer Biol. 1993 Aug;4(4):219-29.
  • Blood CH, Zetter BR.Laminin regulates a tumor cell chemotaxis receptor through the laminin-binding integrin subunit alpha 6.Cancer Res. 1993 Jun 1;53(11):2661-6.
  • Rossi MC, Zetter BR.Selective stimulation of prostatic carcinoma cell proliferation by transferrin.Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6197-201.
  • Meininger CJ, Zetter BR.Mast cells and angiogenesis.Semin Cancer Biol. 1992 Apr;3(2):73-9.
  • Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR.The c-kit receptor ligand functions as a mast cell chemoattractant.Blood. 1992 Feb 15;79(4):958-63.
  • Chan BM, Matsuura N, Takada Y, Zetter BR, Hemler ME.In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells.Science. 1991 Mar 29;251(5001):1600-2.
  • Zetter BR, Brightman SE.Cell motility and the extracellular matrix.Curr Opin Cell Biol. 1990 Oct;2(5):850-6.
  • Zetter BR.The cellular basis of site-specific tumor metastasis.N Engl J Med. 1990 Mar 1;322(9):605-12.
  • Chackal-Roy M, Niemeyer C, Moore M, Zetter BR.Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.J Clin Invest. 1989 Jul;84(1):43-50.
  • Blood CH, Zetter BR.Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide.J Biol Chem. 1989 Jun 25;264(18):10614-20.
  • Zetter BR.Assay of capillary endothelial cell migration.Methods Enzymol. 1987;147:135-44.
  • Zetter BR, Rasmussen N, Brown L.An in vivo assay for chemoattractant activity.Lab Invest. 1985 Sep;53(3):362-8.
  • Netland PA, Zetter BR.Metastatic potential of B16 melanoma cells after in vitro selection for organ-specific adherence.J Cell Biol. 1985 Sep;101(3):720-4.
  • Voyta JC, Via DP, Butterfield CE, Zetter BR.Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein.J Cell Biol. 1984 Dec;99(6):2034-40.
  • Netland PA, Zetter BR.Organ-specific adhesion of metastatic tumor cells in vitro.Science. 1984 Jun 8;224(4653):1113-5.
  • Chodak GW, Scheiner CJ, Zetter BR.Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells.N Engl J Med. 1981 Oct 8;305(15):869-74.
  • Coughlin SR, Moskowitz MA, Zetter BR, Antoniades HN, Levine L.Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor.Nature. 1980 Dec 11;288(5791):600-2.
  • Brouty-Boy D, Zetter BR.Inhibition of cell motility by interferon.Science. 1980 May 2;208(4443):516-8.
  • Zetter BR.Migration of capillary endothelial cells is stimulated by tumour-derived factors.Nature. 1980 May 1;285(5759):41-3.